Skip to main content

Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma

Active, not recruiting · Phase 2 · NCT06676319

Conditions: Asthma

At a glance

Research payments reported, 2025
$3.4M
U.S. investigators named
57
Sites paid
48
Planned or actual enrollment
556

About the trial

Sponsor
Sanofi
Tested
Lunsekimig (drug), Short-Acting Beta Agonists (SABA) (drug), Placebo (drug), Fluticasone/Salmeterol (drug), Budesonide/Formoterol (drug), Budesonide/Albuterol (drug)
Dates
Started 2024-11-07; completion 2027-07-19
Results posted
Not yet

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma. The purpose of this study is to assess the efficacy, safety, and tolerability of add-on therapy with subcutaneous (SC) lunsekimig compared with placebo in male and female participants (aged 18 to 80 years, inclusive) with asthma, who are not currently eligible for biologic treatments. Study details include: * The study duration will be approximately 64 weeks for participants not transitioning into the LTS study and approximately 60 weeks for participants transitioning into the LTS study. * The investigational treatment duration will be up to approximately 52 weeks. * T…

From ClinicalTrials.gov, last updated 2026-09-22. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Sanofi US Services Inc. reported $3.4M in research payments for this study in 2025 (303 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Ib Miami LLC $537,276
  • Helix Biomedics Llc $349,899
  • Tucson Clinical Research Institute Llc $284,583
  • National Clinical Trials Inc $210,577
  • Ok Clinical Research LLC $184,652
  • Tellabio International Research Services Llc $174,661
  • Chandler Clinical Trials Llc $144,503
  • Alfa Medical Research Llc $135,108
  • Beautiful Minds Clinical Research Center $97,954
  • Pensacola Research Consultants Inc Avanza Medical Research Center $93,696
  • Elligo Health Research Inc $84,627
  • Epic Medical Research Llc $77,098
  • Innovo Research Inc $68,889
  • Elias Research Associates LLC $67,292
  • Interspond LLC $59,368
  • University of Michigan Health System, MI $55,255
  • Icahn School of Medicine at Mount Sinai $55,163
  • Carbon Health Technolgies Inc $53,091
  • Brian D Modena Orso Health Inc $52,400
  • Howland Allergy Asthma PLLC Orion Clinical Research $49,591
  • Metroplex Pulmonary and Sleep Center $46,447
  • Javara Inc $42,998
  • Clinical Research Associates of Central PA LLC $41,301
  • Medical College of Wisconsin Inc Attn Donald Basel $37,765
  • Mayo Clinic Cardiology $37,760
  • Pioneer Clinical Research Ny Llc $34,788
  • Velocity Clinical Research Inc $30,600
  • Omega Research Debary Llc $27,750
  • Profound Research Llc $24,606
  • Hannibal Regional Healthcare System Inc $20,900
  • Vantage Clinical Trials Llc $19,115
  • Oviedo Medical Research $18,244
  • Treasure Valley Medical Research Neetu Talreja $17,608
  • Royal Clinical Trials Llc $17,500
  • Staamp Research Llc $17,200
  • Adac Research PA $17,109
  • Axsendo Clinical Research Llc $16,708
  • Bfhc Research Llc $15,800
  • Gmg Clinical Research Llc Radiance Clinical Research $14,950
  • D H Pompano Research Center Llc $14,500
  • Downtown L A Research Center Inc $13,300
  • Hull Hull Medical Specialists LLP Broward Pulmonary and Sleep Specialists $12,500
  • Howard University $12,500
  • Simcare Medical Research Llc $12,500
  • Acevedo Clinical Research Associates Co $8,310
  • Clinical Research PArtners LLC $709
  • Clinical Research Center of Alabama LLC $500
  • Best Skin Research Llc $220

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.